A total of 28 patients ( baseline HbA ( 1c ) range = 6.5-9 .6 % ) receiving metformin were randomized into one of two treatment sequences : the addition of placebo for 4 weeks followed by the addition of sitagliptin 50 mg twice daily ( b.i.d. ) for 4 weeks , or vice versa .
